Current studies into this medication are yielding promising outcomes regarding body composition . Initially developed for treating type 2 diabetes , this GLP-1 receptor agonist has proven impressive https://bookmarkgenius.com/story21352717/semaglutide-research-exploring-new-body-reduction-possibilities